baber/WOPTO huggingface dataset:
Patent AU-2010215486-A1 (AU)
Title: Method for making lactid acid bacteria composition
Inventor: BIRGITTE YDE
IPC: C12N1/04
Filed: 2010-02-18
Abstract: A method for making at least 2 kg (dry weight) of a lactic acid bacteria composition formulated with from 1 % to 50% of ascorbate or ascorbic acid (w/w - dry matter) as antioxidant, wherein the pH is controlled so 3 ≤ pH ≤ 8 during at least the majority of the fermentation process by addition of a base not comprising NH (ammonia).
Patent AU-2010217188-A1 (AU)
Title: Air cleaning apparatus
Inventor: WILLIAM STEINER JOHN
IPC: B01D53/34
Filed: 2010-02-24
Abstract: An air cleaning apparatus (10A) for deodorising or cleaning of air containing noxious or toxic odours is disclosed. The apparatus (10A) includes a controller that is a PLC 1, an air pump (2), a solenoid (3), a manifold (4), a pressure gauge (5), an air supply line (6) and air supply lines (7 and 8) in fluid communication with the manifold (4). It also includes a first tank (12) that contains a deodorising solution, a second tank (13) contains a detoxifying solution and the third tank (14) contains an oxidising / disinfecting solution. These are the components that are delivered into the air to deodorise and / or clean the air. The apparatus (10A) further includes outlet conduits or lines (9, 10 and 17) which are in fluid communication with in line filters (18, 19 and 20) which as shown are in fluid communication with solenoids (21, 22 and 23). The apparatus further includes supply flow conduits (26, 27 and 28) which are in flow communication with an evaporation assembly (29) where a phase change of said decontamination solution occurs to convert it into an activated molecular species.
Patent AU-2010254302-A1 (AU)
Title: Method for wavefield-based data processing including utilizing multiples to determine subsurface characteristics of a subsurface region
Inventor: WEI LIU
IPC: G06T17/05
Filed: 2010-05-21
Abstract: Despite full waveform propagation capabilities offered by reverse time migration or inversion, prior art methods can generate spurious events from multiples and therefore are limited to using data without free-surface multiples. By eliminating or largely reducing artificial transmission of multiples, the enhanced reverse time migration or inversion in the present invention can correctly use data that contain free-surface and internal multiples and improve image quality or properties estimation.
Patent AU-2010259134-A1 (AU)
Title: Lithium-iron disulfide cell design
Inventor: WEIWEI HUANG
IPC: H01M10/0569
Filed: 2010-05-19
Abstract: A lithium-iron disulfide electrochemical cell design is disclosed, relying on judicious selection of the electrolyte, a thicker lithium anode and a cathode with specific characteristics selected to cooperate with the electrolyte. The resulting cell has a reduced interfacial surface area between the anode and the cathode but, surprisingly, maintains excellent high drain rate capacity.
Patent AU-2010260197-A1 (AU)
Title: Method and system for discontinuous reception operation for long term evolution advanced carrier aggregation
Inventor: FONG MO-HAN
IPC: H04L5/00
Filed: 2010-06-15
Abstract: A method for discontinuous reception operation for carrier aggregation comprising: receiving a first set of discontinuous reception parameters for a first carrier and a limited or different set of discontinuous reception parameters for a second carrier; and configuring discontinuous reception parameters on the first carrier and second carrier.
Patent AU-2010260609-A1 (AU)
Title: Catalyst for synthesis of hydrocarbons from CO and H2 and preparation method thereof
Inventor: ZALMANOVICH MORDKOVICH VLADIMIR
IPC: B01J23/75
Filed: 2010-06-15
Abstract: The present invention relates to petrochemistry, gas chemistry, coal chemistry, particularly the invention relates to a catalyst for synthesis of hydrocarbons from CO and H and a preparation method thereof. The catalyst is pelletized and comprises at least Raney cobalt as active component in an amount of 1-40% by weight based on the total weight of the catalyst, metallic aluminium in an amount of 25-94% by weight based on the total weight of the catalyst and a binder in an amount of 5-30% by weight based on the total weight of the catalyst. The present invention provides the catalyst stability to overheating and high productivity of hydrocarbons C-C for synthesis of hydrocarbons from CO and H.
Patent AU-2010267528-A1 (AU)
Title: Local therapeutic release device
Inventor: PENHASI ADEL
IPC: A61K9/16
Filed: 2010-06-24
Abstract: An oral delivery device for the treatment of periodontal disease, the device being in a solid unit dosage form configured for insertion into a periodontal pocket of a patient. The device consists of: (a) a biodegradable pharmaceutically acceptable water-insoluble polymer in the form of a matrix; (b) a therapeutically effective amount of at least one anti-inflammatory agent dispersed within the matrix; (c) optionally a plasticizing agent; (d) optionally at least one of a wetting agent, a suspending agent and a dispersing agent; and (e) optionally an enzymatically biodegradable pharmaceutically acceptable water soluble polymer dispersed within the matrix. The biodegradable water-insoluble polymer is degradable by enzymatic degradation, physical disintegration or a combination thereof. Also disclosed is a periodontal implant comprising the device and a method for the treatment of periodontal disease comprising administering to a periodontal pocket of a patient in need of such treatment the delivery device.
Patent AU-2010275712-A1 (AU)
Title: Device and method for optimizing stereophonic or pseudo-stereophonic audio signals
Inventor: PAR CLEMENS
IPC: H04S5/00
Filed: 2010-04-29
Abstract: The invention allows an optimal selection of those parameters, which form the basis of stereophonic or pseudo-stereophonic signal generation. The user is given means to determine the degree of correlation, the domain of definition, the loudness, and additional parameters of the resulting signals from a psycho-acoustic standpoint, thus avoiding artifacts. By using the invention, highly efficient encoders and decoders can be constructed, which set audio signals designated for replay by way of two or more loudspeakers to a mono signal plus a few parameters. Concrete fields of application are telecommunications (hands-free equipment), global networks, computer systems, emitting and transmitting devices, particularly satellite transmitting devices, professional audio technology, television, film and radio broadcasting, and electronic consumer goods.
Patent AU-2010282289-A1 (AU)
Title: Methods of treating cancer using galanin retargeted endpeptidases
Inventor: JACKY BIRGITTE P S
IPC: A61P35/00
Filed: 2010-08-13
Abstract: The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
Patent AU-2010303902-A1 (AU)
Title: Methods of characterizing small nucleic acid molecules
Inventor: LENNOX RONALD W
IPC: C12P19/34
Filed: 2010-07-30
Abstract: The invention generally relates to methods of characterizing small nucleic acid molecules, such as plasmids or nucleic acid molecules obtained from a virus. In certain embodiments, the invention provides a method of characterizing a small circular nucleic acid molecule, the method including performing rolling circle amplification on a small circular nucleic acid molecule, thereby producing a concatamer, and generating an optical map of the concatamer, thereby characterizing the small circular nucleic acid molecule.
Patent AU-2010305447-A1 (AU)
Title: Process for the preparation of a fermentation product from lignocellulose containing material
Inventor: SMITS JOHANNES PETRUS
IPC: C12P7/10
Filed: 2010-10-05
Abstract: The invention relates to a process for the preparation of a fermentation product from ligno-cellulosic material, comprising the following steps: a) optionally pre-treatment b) optionally washing; c) enzymatic hydrolysis; d) fermentation; and e) optionally recovery of a fermentation product; wherein in step c) an enzyme composition is used that has a temperature optimum of 55 degrees C or more, the hydrolysis time is 40 hours or more and the temperature is 50 degrees C or more.
Patent AU-2010307072-A1 (AU)
Title: Integrated 2D/3D camera
Inventor: PACE VINCENT
IPC: G03B13/32
Filed: 2010-10-08
Abstract: There is disclosed an integrated 2D/3D camera system which may include a 2D camera and a 3D camera affixed to the 2D camera. The 2D camera may include a first lens that is lens adjustable to set a 2D focus distance. The 3D camera may include a left camera and a right camera including respective left and right lenses, the left and right lenses synchronously adjustable to set a 3D focus distance. A focus mechanism may set the 2D focus distance and the 3D focus distance to be essentially equal by at least one of adjusting the first lens and synchronously adjusting the left and right lenses.
Patent WO-2011137486-A1 (WO)
Title: Méthodes de diagnostic et de pronostic et thérapeutiques
Inventor: LIU JUN-PING
IPC: C12N15/06
Filed: 2011-05-04
Abstract: L'invention concerne un essai pour un trouble du comportement caractérisé par une anxiété, tel qu'un trouble obsessivo-compulsif et/ou un trouble lipidique et/ou un trouble du foie associé aux lipides (ci-après « les états ») comprenant l'estimation du taux ou de l'activité d'un analyte choisi parmi le polypeptide ATP13A2, l'acide nucléique  ATP13A2 , Mn 2+  et un complexe comprenant le polypeptide ATP13A2 et Mn 2+ , dans lequel le taux ou l'activité de l'analyte indique que le sujet de l'essai présente ou est susceptible de présenter les états. L'invention concerne également une méthode de traitement ou de prévention employant les essais d'estimation ou le polypeptide ATP13A2 ou l'acide nucléique  ATP13A2 . L'invention concerne également le polypeptide ATP13A2 ou l'acide nucléique  ATP13A2  pour l'utilisation dans le traitement ou la prévention des états dans lesquels le polypeptide ATP13A2 ou l'acide nucléique  ATP13A2  augmente le taux de Mn 2+  mitochondrial chez des sujets présentant un faible taux de Mn 2+  mitochondrial. L'invention concerne également une cellule isolée ou un organisme comprenant ceux-ci, dans lesquels l'activité du polypeptide ATP13A2 est modifiée, par exemple réduite ou inhibée (éliminée). L'invention concerne également un essai pour des agents qui complètent le phénotype d'une cellule déficiente en ATP13A2 ou d'un organisme non humain comprenant de telles cellules, l'essai comprenant la mise en contact de la cellule ou de l'organisme avec un agent putatif et l'estimation de la capacité de l'agent à augmenter le taux de Mn 2+  mitochondrial dans la cellule. L'invention concerne également un essai pour des agents qui modulent les taux de Mn 2+  dans une cellule ou dans un organisme, l'essai comprenant la mise en contact de la cellule ou de l'organisme avec un agent putatif et l'estimation de la capacité de l'agent à augmenter le taux ou l'activité de ATP13A2 dans la cellule ou dans l'organisme.
Patent AU-2011200285-A1 (AU)
Title: Traffic signal controller system and method
Inventor: JAMES ALDRIDGE KEITH
IPC: G08G1/07
Filed: 2011-01-24
Abstract: Abstract A traffic signal controller system for controlling the operation of a set of traffic lights, the traffic signal controller system including: an uninterruptible power supply (UPS), interconnected to the traffic signal controller system to maintain the continued 5 operation of the set of traffic lights during any short term interruption to the power supply of the traffic signal controller system.
Patent AU-2011205082-A1 (AU)
Title: Sanitising antimicrobial compositions
Inventor: PALM DANIEL
IPC: A01P1/00
Filed: 2011-07-29
Abstract: Abstract The invention provides antimicrobial compositions comprising an essential oil, an alcohol and a metal ion source and methods of use thereof.
Patent AU-2011207052-A1 (AU)
Title: Building Block for Construction of Buildings and its Procedures
Inventor: RODRIGUEZ OSVALDO NESTOR
IPC: E04B1/19
Filed: 2011-01-19
Abstract: The invention relates to the construction of buildings, especially a reticulated stereo modular element that, combined with other identical elements, enables the construction of quadrangular enclosures suitable for the construction of rooms.
Patent AU-2011207544-A1 (AU)
Title: Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing
Inventor: RAVA RICHARD P
IPC: C12Q1/68
Filed: 2011-01-19
Abstract: The present invention relates to methods comprising whole genome sequencing for identifying polymorphisms in samples comprising mixtures of genomes, and for determining and/or monitoring the presence or absence of disorders associated with the identified polymorphisms.
Patent AU-2011225828-A1 (AU)
Title: Process,tube and device for the preparation of wound healant composition
Inventor: TURZI ANTOINE
IPC: A61K35/15
Filed: 2011-03-11
Abstract: The present invention is related to the field of tissue regeneration. It concerns more particularly new processes, tubes and devices for thrombin, platelet concentrate and wound healant preparations, alone or in combination with cell extracts, cell compositions and uses thereof..
Patent AU-2011245372-A1 (AU)
Title: Predictive markers useful in the treatment of Fragile X Syndrome (FXS)
Inventor: GOMEZ-MANCILLA BALTAZAR
IPC: C12Q1/68
Filed: 2011-04-28
Abstract: The invention is directed to the use of biomarkers to determine responsiveness of an individual with Fragile X Syndrome (FXS) to treatment with an mGluR5 antagonist.
Patent AU-2011253780-A1 (AU)
Title: Methods and apparatus for providing network broadcast information to WLAN enabled wireless communication devices
Inventor: ROBERTAS KEZYS VYTAUTAS
IPC: H04L12/28
Filed: 2011-12-01
Abstract: METHODS AND APPARATUS FOR PROVIDING NETWORK BROADCAST INFORMATION TO WLAN ENABLED WIRELESS COMMUNICATION A method of providing network information to a wireless device (102) in a local area network (190) includes the steps of providing a network interworking indicator to the wireless device; receiving a request message from the wireless device for requesting the network information which is associated which identifies one or more networks; and, in response to the request message, providing the network information in a generic container message for transmission to the wireless device. The generic container message includes a container for providing the network information which is formatted in accordance with at least one of: a technology, a standards organization, or a protocol.
Patent AU-2011271603-A1 (AU)
Title: Submerged entry nozzle
Inventor: RICHAUD JOHAN
IPC: B22D41/50
Filed: 2011-05-11
Abstract: A pour tube for casting molten metal is adapted to reduce turbulence and mold disturbances, thereby producing a more stable, uniform outflow. The pour tube includes a bore having a body in communication with an enlarged outlet portion. Exit ports in communication with the outlet portion have an offset design in which at least one wall of the exit port is tangent to a circle having a larger radius than the body of the bore.
Patent AU-2011276313-A1 (AU)
Title: Degradable superabsorbent polymers
Inventor: SELIFONOV SERGEY
IPC: A01N25/26
Filed: 2011-07-05
Abstract: The present disclosure relates to degradable superabsorbent materials based on acetals of glyoxylic acid and derivatives thereof with polyvinyl alcohol, and methods of making the polymers. The polymers are used to make superabsorbent particles, coatings, sheets, and fibers. Formulations and articles including the superabsorbent polymers, particles, coatings, sheets, and fibers are also disclosed.
Patent AU-2011281173-A1 (AU)
Title: Derivatives of oxadiazole and pyridazine, their preparation and their application in therapeutics
Inventor: FETT EYKMAR
IPC: C07D237/20
Filed: 2011-07-22
Abstract: The invention relates to compounds of formula (I): in which: n is equal to 0 or 1; D represents an oxygen atom or a bond; W represents a nitrogen atom or a -CH- group; X1 represents a nitrogen atom or a -CH=CH- group; X2 represents an oxygen atom or a nitrogen atom; X3 represents an oxygen atom or a nitrogen atom; one of X1, X2, X3 being other than a nitrogen atom, X2 and X3 not being an oxygen atom at the same time; R1, R2 are absent or represent, (i) independently of one another, a hydrogen atom or a (C1 -C4)alkyl group, (ii) R1 and R2 may form, with the carbon atom to which they are attached, a -(C3-C10)cycloalkyl- group; Y represents a -(C3-C10)cycloalkyl-, aryl or aryloxy group, said groups being optionally substituted with one or more substituents chosen from a halogen atom or a (C1 -C6)alkoxy group; Z1 is absent or represents an -NH- function; Z2 and Z3 are as defined in the description. The invention also relates to a process for preparing compounds of formula (I), compositions containing them and their application in therapeutics.
Patent AU-2011292257-A1 (AU)
Title: Method and device for optical alert recognition
Inventor: HEYDLAUF MICHAEL
IPC: G06F11/00
Filed: 2011-08-15
Abstract: A method for remotely displaying an error state of a controller or an assay testing instrument via a network. The method includes generating and transmitting display image data representing the operating status of the controller; receiving the display image data transmitted by the controller at a remote monitoring unit; displaying the display image data on a display device; comparing high resolution display image data to alert (error) image data stored in a database; and generating an error alert message indicative of the error state when any of the display images matches one of the error alert image.
Patent AU-2011353283-A1 (AU)
Title: siRNA for inhibition of Hif1alpha expression and anticancer composition containing the same
Inventor: KIM SUN-OK
IPC: A61P35/00
Filed: 2011-12-29
Abstract: Disclosed are small interfering RNA (siRNA) that complementarily binds to a base sequence of Hif1α mRNA transcript, thereby inhibiting expression of Hif1α without inducing immune responses, and a use of the siRNA for prevention and/or treatment of cancer. Since Hif1α is commonly overexpressed in almost all cancer cells, the siRNA that complementarily binds to Hif1α-encoding mRNA may inhibit expression of Hif1α through RNA-mediated interference (RNAi), thereby inhibiting proliferation and metastasis of cancer cells, and thus, the siRNA may be useful as an anticancer agent.
Patent AU-2011356277-A1 (AU)
Title: Personal EEG monitoring device with electrode validation
Inventor: KIDMOSE PREBEN
IPC: A61B5/374
Filed: 2011-01-20
Abstract: A personal wearable EEG monitor (1) is adapted to be carried at the head of a person. The EEG monitor comprises an EEG sensor part having skin surface electrodes (3) for measuring EEG signals from said person. The EEG monitor comprises an EEG signal analyzer (5, 5') adapted for having an EEG signal transferred from the EEG sensor part, and adapted for monitoring the EEG signal. The EEG monitor (1) further comprises EEG stimuli controlling means adapted for performing at least one of the following: providing a stimulus to the person, requesting the person to perform a stimuli creating act, or identifying a stimuli creating ambient sound. The EEG monitor comprises EEG response detection means for identifying an induced response from the EEG signal caused by the stimuli, and a classifier for deciding based on said induced response if the skin surface electrodes receive EEG signals.
Patent AU-2012200041-A1 (AU)
Title: Air pollution control system and air pollution control method
Inventor: IIJIMA MASAKI
IPC: B01D53/62
Filed: 2012-01-05
Abstract: An air pollution control system includes a desulfurization apparatus 13 that reduces sulfur oxide contained in flue gas 12 supplied from a boiler 11; and a 5 C02 recovery apparatus 15 including a C02 absorber 21 that reduces C02 contained in flue gas 12 that has been desulfurized by the desulfurization apparatus, with the aid of an amine absorbent and an absorbent regenerator 22 that regenerates the amine absorbent. Part 14a of desulfurized 10 flue gas 14 containing SOx is supplied to treated flue gas 16, from which C02 has been reduced and which is discharged from a top portion of the C02 absorber 21, so that remaining mist amine accompanying the treated flue gas 16 is neutralized to amine sulfate or amine sulfite. (00 < L-J U--
Patent AU-2012205301-A1 (AU)
Title: Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
Inventor: BARFIELD ROBYN M
IPC: C07K16/08
Filed: 2012-01-13
Abstract: The present disclosure provides aldehyde-tagged immunoglobulin (Ig) polypeptides that can be converted by a formylglycine-generating enzyme to produce a 2-formylglycine (FGly)-modified Ig polypeptide. An FGly-modified Ig polypeptide can be covalently and site-specifically bound to a moiety of interest to provide an Ig conjugate. The disclosure also encompasses methods of production of such aldehyde-tagged Ig polypeptides, FGly-modified Ig polypeptides, and Ig conjugates, as well as methods of use of same.
Patent AU-2012206954-A1 (AU)
Title: A compression garment for animals
Inventor: SPICE MATTHEW
IPC: A01K13/00
Filed: 2012-01-15
Abstract: The present invention relates to a compression garment (10) for clothing a body part of an animal (4). The garment (10) includes a section adapted to contain or include one or more therapeutic or protective materials which in use cover one or more selected areas of the body part. The garment (10) also includes a plurality of panels (2) of stretchable material joined to one another by seams. The seams are designed to exert gradient compressional force on the or each selected area of the body part.
Patent AU-2012216266-A1 (AU)
Title: Fused cyclic compounds
Inventor: YASUMA TSUNEO
IPC: A61K31/192
Filed: 2012-08-16
Abstract: R2f B Y - COR (1) R'--X-O. -R5 The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like. 35849942 (GHMatters) P79845.AU 1
Patent AU-2012224632-A1 (AU)
Title: 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
Inventor: TRABANCO-SUAREZ ANDRES AVELINO
IPC: A61K31/506
Filed: 2012-03-07
Abstract: The present invention relates to novel 3,4-dihydro-pyrrolo[l,2-a]pyrazin-1-ylamine derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease or dementia associated with beta-amyloid.